MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genes

Oncogenesis

Volumn 2, Issue , 2013, Pages

  Nath, S ^a   Daneshvar, K ^a   Roy, L D ^a   Grover, P ^a   Kidiyoor, A ^a   Mosley, L ^a   Sahraei, M ^a   Mukherjee, P ^a  

^a UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

Author keywords

ABCC1 (MRP1); mucin 1 cytoplasmic tail; mucin1 tandem repeat; multidrug resistance; pancreatic cancer; PI3K Akt

Indexed keywords

ETOPOSIDE; GEMCITABINE; MUCIN 1; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 3; MULTIDRUG RESISTANCE PROTEIN 5;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84879824031     PISSN: None     EISSN: 21579024     Source Type: Journal    
DOI: 10.1038/oncsis.2013.16     Document Type: Article

References (30)

1. Bardeesy N, DePinho RA. Pancreatic cancer biology and genetics. Nat Rev Cancer 2002; 2: 897-909. (Pubitemid 37328891)
2. Strimpakos A, Saif MW, Syrigos KN. Pancreatic cancer: from molecular pathogenesis to targeted therapy. Cancer Metastasis Rev 2008; 27: 495-522.
3. Konig J, Hartel M, Nies AT, Martignoni ME, Guo J, Bü chler MW et al. Expression and localization of human multidrug resistance protein (ABCC) family members in pancreatic carcinoma. Int J Cancer 2005; 115: 359-367. (Pubitemid 40663738)
4. Sperti C, Pasquali C, Piccoli A, Pedrazzoli S. Recurrence after resection for ductal adenocarcinoma of the pancreas. World J Surg 1997; 21: 195-200. (Pubitemid 27053441)
5. Wang Z, Li Y, Ahmad A, Banerjee S, Azmi AS, Kong D et al. Pancreatic cancer: understanding and overcoming chemoresistance. Nat Rev Gastroenterol Hepatol 2011; 8: 27-33.
6. Jager w. Classical resistance mechanisms. Int J Clin Pharmacol Ther 2009; 47: 46-48.
7. Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATPdependent transporters. Nat Rev Cancer 2002; 2: 48-58. (Pubitemid 37328807)
8. Misra S, Ghatak S, Toole BP. Regulation of MDR1 expression and drug resistance by a positive feedback loop involving hyaluronan, phosphoinositide 3-kinase, and ErbB2. J Biol Chem 2005; 280: 20310-20315. (Pubitemid 40776728)
9. Sharom FJ. ABC multidrug transporters: structure, function and role in chemoresistance. Pharmacogenomics 2008; 9: 105-127. (Pubitemid 351560534)
10. Lee Jr JT, Steelman LS, McCubrey JA. Phosphatidylinositol 3'-kinase activation leads to multidrug resistance protein-1 expression and subsequent chemoresistance in advanced prostate cancer cells. Cancer Res 2004; 64: 8397-8404. (Pubitemid 39491779)
11. Raina D, Kharbanda S, Kufe D. The MUC1 oncoprotein activates the anti-apoptotic phosphoinositide 3-kinase/Akt and Bcl-xL pathways in rat 3Y1 fibroblasts. J Biol Chem 2004; 279: 20607-20612. (Pubitemid 38656454)
12. Siragusa M, Zerilli M, Iovino F, Francipane MG, Lombardo Y, Ricci-Vitiani L et al. MUC1 oncoprotein promotes refractoriness to chemotherapy in thyroid cancer cells. Cancer Res 2007; 67: 5522-5530. (Pubitemid 46997294)
13. Hollingsworth MA, Swanson BJ. Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer 2004; 4: 45-60. (Pubitemid 38082153)
14. Levi E, Klimstra DS, Andea A, Basturk O, Adsay NV. MUC1 and MUC2 in pancreatic neoplasia. J Clin Pathol 2004; 57: 456-462. (Pubitemid 38621788)
15. Chhieng DC, Benson E, Eltoum I, Eloubeidi MA, Jhala N, Jhala D et al. MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration. Cancer 2003; 99: 365-371. (Pubitemid 38017536)
16. Gendler SJ. MUC1, the renaissance molecule. J Mammary Gland Biol Neoplasia 2001; 6: 339-353.
17. Kufe DW. Mucins in cancer: function, prognosis and therapy. Nat Rev Cancer 2009; 9: 874-885.
18. Carson DD. The cytoplasmic tail of MUC1: a very busy place. Sci Signal 2008; 1: pe35.
19. Besmer DM, Curry JM, Roy LD, Tinder TL, Sahraei M, Schettini J et al. Pancreatic ductal adenocarcinoma mice lacking mucin 1 have a profound defect in tumor growth and metastasis. Cancer Res 2011; 71: 4432-4442.
20. Roy LD, Sahraei M, Subramani DB, Besmer D, Nath S, Tinder TL et al. MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition. Oncogene 2011; 30: 1449-1459.
21. Sahraei M, Roy LD, Curry JM, Teresa TL, Nath S, Besmer D et al. MUC1 regulates PDGFA expression during pancreatic cancer progression. Oncogene 2012; 31: 4935-4945.
22. Behrens ME, Grandgenett PM, Bailey JM, Singh PK, Yi CH, Yu F et al. The reactive tumor microenvironment: MUC1 signaling directly reprograms transcription of CTGF. Oncogene 2010; 29: 5667-5677.
23. Ren J, Agata N, Chen D, Li Y, Yu WH, Huang L et al. Human MUC1 carcinomaassociated protein confers resistance to genotoxic anticancer agents. Cancer Cell 2004; 5: 163-175. (Pubitemid 38283802)
24. Scotto KW. Transcriptional regulation of ABC drug transporters. Oncogene 2003; 22: 7496-7511. (Pubitemid 37487172)
25. Kurz EU, Cole SP, Deeley RG. Identification of DNA-protein interactions in the 5' flanking and 5' untranslated regions of the human multidrug resistance protein (MRP1) gene: evaluation of a putative antioxidant response element/AP-1 binding site. Biochem Biophys Res Commun 2001; 285: 981-990. (Pubitemid 32918034)
26. Thompson EJ, Shanmugam K, Hattrup CL, Kotlarczyk KL, Gutierrez A, Bradley JM et al. Tyrosines in the MUC1 cytoplasmic tail modulate transcription via the extracellular signal-regulated kinase 1/2 and nuclear factor-kappaB pathways. Mol Can Res 2006; 4: 489-497. (Pubitemid 44197044)
27. Behrens ME, Grandgenett PM, Bailey JM, Singh PK, Yi CH, Yu F et al. The reactive tumor microenvironment: MUC1 signaling directly reprograms transcription of CTGF. Oncogene 2010; 29: 5667-5677.
28. Sahraei M, Roy LD, Curry JM, Teresa TL, Nath S, Besmer D et al. MUC1 regulates PDGFA expression during pancreatic cancer progression. Oncogene 2012; 31: 4935-4945.
29. Hingorani SR, Petricoin EF, Maitra A, Rajapakse V, King C, Jacobetz MA et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 2003; 4: 437-450. (Pubitemid 38050041)
30. Tinder TL, Subramani DB, Basu GD, Bradley JM, Schettini J, Million A et al. MUC1 enhances tumor progression and contributes toward immunosuppression in a mouse model of spontaneous pancreatic adenocarcinoma. J Immunol 2008; 181: 3116-3125.